Combioxin SA

Swiss Biotech Association

Not a member

Combioxin aims at becoming a market leader in non-traditional therapies for severe and resistant infections.

http://www.combioxin.com

Location

8 Rue de la Rôtisserie, 1204 Geneva, Switzerland

Facts & figures

Type of organization

Private company
Year of foundation

2015
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology development group of companies with the vision to leverage ground-breaking technology to bring game-changing therapies to patients living with cancer.
Hünenberg

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
6850 Mendrisio